Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Showing 20 of 0 results

Not applicableEnded earlyNCT00768001
What this trial is testing

Genetic Analysis of Liver Cancer

Who this might be right for
Liver CancerHepatitis BHepatitis C+2 more
Samuel So 41
Early research (Phase 1)Study completedNCT00728936
What this trial is testing

Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients

Who this might be right for
Hepatitis C
Idera Pharmaceuticals, Inc. 58
Early research (Phase 1)Study completedNCT01323257
What this trial is testing

TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)

Who this might be right for
Hepatitis C Virus
Tibotec Pharmaceuticals, Ireland 49
Not applicableEnded earlyNCT01716403
What this trial is testing

Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy

Who this might be right for
C Hepatitis, Tri Therapy
University Hospital, Grenoble 8
Not applicableStudy completedNCT03415009
What this trial is testing

Prevalence of IL28B Polymorphism in Hepatitis C Patients

Who this might be right for
Hepatitis C
Changi General Hospital 39
Post-approval studies (Phase 4)UnknownNCT01896609
What this trial is testing

Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population

Who this might be right for
Chronic Hepatitis c
MinaPharm Pharmaceuticals 300
Large-scale testing (Phase 3)Study completedNCT01281839
What this trial is testing

An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy

Who this might be right for
Hepatitis C
Janssen R&D Ireland 394
Post-approval studies (Phase 4)Study completedNCT00207311
What this trial is testing

Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus

Who this might be right for
Fatty LiverHepatitis C
Brooke Army Medical Center 30
Not applicableStudy completedNCT04873609
What this trial is testing

Electronic Record Assimilation and Subsequent Eradication of Hepatitis C

Who this might be right for
Hepatitis CLiver Diseases
Stanford University 1,600
Not applicableActive Not RecruitingNCT01858012
What this trial is testing

Insulin Resistance in HCV Infection

Who this might be right for
Insulin Resistance
University of California, San Francisco 250
Not applicableStudy completedNCT02532907
What this trial is testing

Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs

Who this might be right for
Hepatitis C
University of Colorado, Denver 5
Not applicableStudy completedNCT00514111
What this trial is testing

Factors Associated to Success of Hepatitis C Therapy

Who this might be right for
Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
UPECLIN HC FM Botucatu Unesp 100
Not applicableStudy completedNCT04971330
What this trial is testing

Access Anti-HCV Assay European Union (EU) Clinical Trial Protocol

Who this might be right for
HCV
Beckman Coulter, Inc. 7,901
Post-approval studies (Phase 4)UnknownNCT01105611
What this trial is testing

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Who this might be right for
HIV InfectionsHepatitis C
St. James's Hospital, Ireland 40
Post-approval studies (Phase 4)Study completedNCT03823911
What this trial is testing

Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

Who this might be right for
Cardiovascular DiseasesHepatitis CHiv
University of Maryland, Baltimore 87
Testing effectiveness (Phase 2)Study completedNCT01359644
What this trial is testing

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 350
Post-approval studies (Phase 4)Study completedNCT02339337
What this trial is testing

A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection

Who this might be right for
HBV/HCV Co-infection
Kaohsiung Medical University Chung-Ho Memorial Hospital 203
Not applicableStudy completedNCT03313154
What this trial is testing

Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related

Who this might be right for
Psychiatric DisordersCognitive ImpairmentChronic Hepatitis c
Azienda Ospedaliero Universitaria di Cagliari 100
Not applicableStudy completedNCT00724854
What this trial is testing

Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 1,146
Early research (Phase 1)Study completedNCT01453075
What this trial is testing

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

Who this might be right for
Chronic Hepatitis C Infection
VA Office of Research and Development 31
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation